T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Woodward
WWD
$21.4B
| $75.3M | 0.02% |
1,529,043
-298,657
| -16% | -$14.8M |
|
702
CSX Corp
CSX
$92.8B
| $75M | 0.02% |
6,209,931
+100,260
| +2% | +$1.17M |
|
703
AZZ Inc
AZZ
$4.55B
| $74.9M | 0.02% |
1,595,778
+27,410
| +2% | +$1.24M |
|
704
Prosperity Bancshares
PB
$8.95B
| $74.7M | 0.02% |
1,349,260
+71,400
| +6% | +$4.05M |
|
705
American Eagle Outfitters
AEO
$2.72B
| $74.7M | 0.02% |
5,378,910
-1,307,500
| -20% | -$17.7M |
|
|
SONC
706
DELISTED
Sonic Corp
SONC
| $74.6M | 0.02% |
2,737,907
-660,230
| -19% | -$16.7M |
|
707
SPS Commerce
SPSC
$2.75B
| $74.5M | 0.02% |
2,632,800
+21,200
| +0.8% | +$607K |
|
|
CCMP
708
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $74.1M | 0.02% |
1,566,806
-214,570
| -12% | -$9.82M |
|
709
Constellium
CSTM
$4B
| $74M | 0.02% |
4,505,891
+144,260
| +3% | +$2.69M |
|
710
Novavax
NVAX
$1.31B
| $73.4M | 0.02% |
618,855
+23,280
| +4% | +$2.43M |
|
711
TIM SA
TIMB
$8.69B
| $73.3M | 0.02% |
3,298,222
-525,448
| -14% | -$12.5M |
|
712
Kimberly-Clark
KMB
$36.2B
| $73.2M | 0.02% |
633,125
-15,522
| -2% | -$1.72M |
|
713
Selective Insurance
SIGI
$5.59B
| $72.8M | 0.02% |
2,677,730
+12,660
| +0.5% | +$323K |
|
|
TESO
714
DELISTED
Tesco Corp
TESO
| $72.7M | 0.02% |
5,671,380
+2,363,085
| +71% | +$36.9M |
|
|
PCH
715
DELISTED
PotlatchDeltic
PCH
| $72.2M | 0.02% |
1,723,860
-368,910
| -18% | -$15.5M |
|
716
General Dynamics
GD
$107B
| $72.1M | 0.02% |
523,614
-3,790
| -0.7% | -$516K |
|
|
TRAK
717
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $71.9M | 0.02% |
1,621,850
+480,050
| +42% | +$21.4M |
|
718
Monster Beverage
MNST
$90.1B
| $71.7M | 0.02% |
7,945,368
-708,204
| -8% | -$6.11M |
|
719
Prothena Corp
PRTA
$475M
| $71.3M | 0.02% |
3,436,496
+490,300
| +17% | +$10.2M |
|
720
SM Energy
SM
$7.71B
| $70.6M | 0.02% |
1,829,372
-4,744,244
| -72% | -$238M |
|
721
Baxter International
BAX
$13.9B
| $70.5M | 0.02% |
1,772,090
+48,842
| +3% | +$1.9M |
|
|
FARO
722
DELISTED
Faro Technologies
FARO
| $70.5M | 0.02% |
1,125,210
+5,950
| +0.5% | +$327K |
|
|
CRC
723
DELISTED
California Resources Corporation
CRC
| $70.3M | 0.01% |
+1,275,352
| New | +$76.8M |
|
|
KAMN
724
DELISTED
Kaman Corp
KAMN
| $70.2M | 0.01% |
1,751,542
-13,900
| -0.8% | -$557K |
|
725
Genworth Financial
GNW
$3.79B
| $69.6M | 0.01% |
8,189,387
+7,348,287
| +874% | +$77.2M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.